Gapping up
In reaction to strong earnings/guidance: SVT +4.1%, BLRX +1.9%, DSKY +1.7%
M&A news: THC +4.8% (confirms that it and United Surgical Partners International will combine their ambulatory surgery and imaging centers in new JV; Tenet also announces purchase of Aspen Healthcare), SAN +1.5% (reports co plans to make bid for Novo Banco)
Other news: MCP +25% (60 Minutes reported on importance of rare earth elements), IMGN +22.4% (announces that Takeda (TKPYY) has licensed exclusive rights to use ImmunoGen's ADC technology to develop and commercialize targeted anticancer therapeutics to up to two undisclosed targets), FRSH +8.6% (favorable commentary on Friday's Mad Money), CANF +7.5% (signs multi-million dollar distribution agreement for CF101 in Canada with Cipher Pharmaceuticals (CPHR)), KMDA +6.1% (announces that the European Commission has designated its human intravenous Alpha-1 Antitrypsin as an orphan medicinal product to treat Graft-versus-host disease), NBG +4.5% (cont volatility surrounding Greece), CRNT +4.3% (announced that a Tier 1 mobile operator in Africa is investing approximately $4 million to expand its large scale Ceragon-based backbone network), BTN +4.2% (Issues statement in response to proxy contest), ESLT +1.3% (U.S. subsidiary awarded a $73.4 mln USMC IDIQ contract for Common Laser Range Finder), BLBD +1.1% (announces 92 Blue Bird propane-fueled school buses will power fleet of school vehicles in Colorado; also Hennessy Capital discloses 13.4% active stake in 13D filing), PAA +1.1% (Joint Venture with Delek Logistics to Build Caddo Pipeline)
Analyst comments: CAPN +9.9% (initiated with a Buy at Maxim Group), DVAX +5.9% (upgraded to Overweight from Neutral at JP Morgan; tgt raised to $36 from $15), GNW +5.7% (upgraded to Strong Buy from Outperform at Raymond James), NMM +5.3% (upgraded to Buy from Hold at Deutsche Bank), CYBR +3.6% (initiated with a Buy at BofA/Merrill), ITEK +3.5% (initiated with a Buy at Canaccord Genuity), SPLS +2.7% (upgraded to Buy from Neutral at UBS), AMH +1.8% (upgraded to Overweight from Equal-Weight at Morgan Stanley), MSCC +0.9% (initiated with an Outperform at BMO Capital), TYC +0.8% (upgraded to Overweight at Barclays), AAPL +0.8% (target raised to $135 from $115 at Cowen)
In reaction to strong earnings/guidance: SVT +4.1%, BLRX +1.9%, DSKY +1.7%
M&A news: THC +4.8% (confirms that it and United Surgical Partners International will combine their ambulatory surgery and imaging centers in new JV; Tenet also announces purchase of Aspen Healthcare), SAN +1.5% (reports co plans to make bid for Novo Banco)
Other news: MCP +25% (60 Minutes reported on importance of rare earth elements), IMGN +22.4% (announces that Takeda (TKPYY) has licensed exclusive rights to use ImmunoGen's ADC technology to develop and commercialize targeted anticancer therapeutics to up to two undisclosed targets), FRSH +8.6% (favorable commentary on Friday's Mad Money), CANF +7.5% (signs multi-million dollar distribution agreement for CF101 in Canada with Cipher Pharmaceuticals (CPHR)), KMDA +6.1% (announces that the European Commission has designated its human intravenous Alpha-1 Antitrypsin as an orphan medicinal product to treat Graft-versus-host disease), NBG +4.5% (cont volatility surrounding Greece), CRNT +4.3% (announced that a Tier 1 mobile operator in Africa is investing approximately $4 million to expand its large scale Ceragon-based backbone network), BTN +4.2% (Issues statement in response to proxy contest), ESLT +1.3% (U.S. subsidiary awarded a $73.4 mln USMC IDIQ contract for Common Laser Range Finder), BLBD +1.1% (announces 92 Blue Bird propane-fueled school buses will power fleet of school vehicles in Colorado; also Hennessy Capital discloses 13.4% active stake in 13D filing), PAA +1.1% (Joint Venture with Delek Logistics to Build Caddo Pipeline)
Analyst comments: CAPN +9.9% (initiated with a Buy at Maxim Group), DVAX +5.9% (upgraded to Overweight from Neutral at JP Morgan; tgt raised to $36 from $15), GNW +5.7% (upgraded to Strong Buy from Outperform at Raymond James), NMM +5.3% (upgraded to Buy from Hold at Deutsche Bank), CYBR +3.6% (initiated with a Buy at BofA/Merrill), ITEK +3.5% (initiated with a Buy at Canaccord Genuity), SPLS +2.7% (upgraded to Buy from Neutral at UBS), AMH +1.8% (upgraded to Overweight from Equal-Weight at Morgan Stanley), MSCC +0.9% (initiated with an Outperform at BMO Capital), TYC +0.8% (upgraded to Overweight at Barclays), AAPL +0.8% (target raised to $135 from $115 at Cowen)